The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma.
about
The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy.Visual and semiquantitative 11C-methionine PET: An independent prognostic factor for survival of newly diagnosed and treatment naive gliomas.RESOLUTE PET/MRI Attenuation Correction for O-(2-18F-fluoroethyl)-L-tyrosine (FET) in Brain Tumor Patients with Metal Implants.Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment-A Review From the Melanoma Perspective and Beyond
P2860
The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma.
@en
The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma.
@nl
type
label
The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma.
@en
The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma.
@nl
prefLabel
The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma.
@en
The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma.
@nl
P2093
P2860
P1476
The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma.
@en
P2093
Hans Skovgaard Poulsen
Ib Jarle Christensen
Kirsten Grunnet
Michael Lundemann Jensen
Per Munck Af Rosenschöld
Sidsel Højklint Poulsen
Thomas Urup
Vibeke Andrée Larsen
P2860
P2888
P304
P356
10.1007/S00259-016-3494-2
P50
P577
2016-08-23T00:00:00Z